Clinical Research

Abbott today announced results from a post-hoc sub-analysis of the 52-week HUMIRA® (adalimumab) ULTRA 2 study. Results of the analysis showed clinically meaningful rates of mucosal healing at week…

ROX Medical announced the first patient enrollment in the CONTROL-HTN international randomized controlled trial of the ROX FLOW procedure for the treatment of resistant hypertension (high blood…

A neuroprotectant drug has been shown to protect the human brain against the damaging effects of stroke. The clinical trial was a randomized, double blind, multi-center trial that was conducted in…

 Apollo Hospitals performed a complex spinal surgery on a 10-year-old child, the 12th successful surgery done within 10 days of the launch of Renaissance Robotic Technology, the only technology…

Obesity is not just happening in New York City 7-Elevens(1), it is also happening in aging bones. Bone marrow stem cells, which are adult stem cells, are in their fifth decade of uncontroversial new…

esverlogix Corp. today announced that the BET protein inhibitor RVX-208 significantly increased HDL-C (p=0.001), the primary endpoint of the SUSTAIN trial, a phase 2b clinical study. SUSTAIN also…

A large study published in Human Reproduction (1) looked at the effect of induced abortions on a subsequent first birth and found that women who have had three or more abortions have a higher risk of…

Oxford BioMedica plc biopharmaceuticals and its partner Sanofi announced a positive interim review of the RetinoStat(R) Phase I study in neovascular "wet" age-related macular degeneration (AMD) and…

Affinium Pharmaceuticals announced today that full recruitment has been achieved in its multi-center Phase 2 clinical trial evaluating oral AFN-1252 in acute bacterial skin&skin structure…

Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the Omnilink Elite® Vascular Balloon-Expandable Stent System for the treatment of iliac artery disease, a form of…